BLAC
Bellevue Life Sciences Acquisition Corp Common Stock
Bellevue Life Sciences Acquisition Corp Common Stock 13F Holders
BLAC Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $10.10
1 value investing guru has made changes to the Bellevue Life Sciences Acquisition Corp Common Stock (BLAC) position according to the gurus' 2023 Q1 SEC quarterly report(s). BLAC has been bought (as a new position) by 1 guru(s)
Which gurus or hedge funds bought BLAC in 2023 Q1?
According to the 2023 Q1 SEC filing(s) Bellevue Life Sciences Acquisition Corp Common Stock (BLAC) has been bought by Howard Marks - Oaktree Capital Management (new buy).
To see more about who is investing in Bellevue Life Sciences Acquisition Corp Common Stock (BLAC), please go to the BLAC ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.